A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia

Por Connor, Kathryn M., Mahoney, Erin, Jackson, Saheeda, Hutzelmann, Jill, Zhao, Xin, Jia, Nan, Snyder, Ellen, Snavely, Duane, Michelson, David, Roth, Thomas, Herring, W. Joseph
Publicado no Int J Neuropsychopharmacol (2016)

Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder

Por Connor, Kathryn M, Ceesay, Paulette, Hutzelmann, Jill, Snavely, Duane, Krystal, Andrew D, Trivedi, Madhukar H, Thase, Michael, Lines, Christopher, Herring, W Joseph, Michelson, David
Publicado no Int J Neuropsychopharmacol (2017)

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials

Por Herring, W. Joseph, Connor, Kathleen M., Snyder, Ellen, Snavely, Duane B., Zhang, Ying, Hutzelmann, Jill, Matzura-Wolfe, Deborah, Benca, Ruth M., Krystal, Andrew D., Walsh, James K., Lines, Christopher, Roth, Thomas, Michelson, David
Publicado no J Clin Sleep Med (2016)